Literature DB >> 8950569

Epidemiology of pulmonary colonization with Burkholderia cepacia in cystic fibrosis patients. The French Observatoire Burkholderia cepacia Study Group.

C Segonds, G Chabanon, G Couetdic, Y Michel-Briand, E Bingen.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8950569     DOI： 10.1007/bf01701534

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  10 in total

1.  Low incidence of pulmonary Pseudomonas cepacia infection in Danish cystic fibrosis patients.

Authors:  M Nir; H K Johansen; N Høiby
Journal:  Acta Paediatr       Date:  1992-12       Impact factor: 2.299

2.  Pseudomonas cepacia--more than a harmless commensal?

Authors: 
Journal:  Lancet       Date:  1992-06-06       Impact factor: 79.321

3.  Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.

Authors:  J R Govan; P H Brown; J Maddison; C J Doherty; J W Nelson; M Dodd; A P Greening; A K Webb
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

4.  In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia.

Authors:  C Lewin; C Doherty; J Govan
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

Review 5.  The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.

Authors:  O C Tablan; W J Martone; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

6.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

7.  Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis.

Authors:  D R Burdge; E M Nakielna; M A Noble
Journal:  Infect Control Hosp Epidemiol       Date:  1993-03       Impact factor: 3.254

8.  The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain.

Authors:  L Sun; R Z Jiang; S Steinbach; A Holmes; C Campanelli; J Forstner; U Sajjan; Y Tan; M Riley; R Goldstein
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

9.  [Bacteriology of mucoviscidosis during a 5-year period].

Authors:  A Ferrer; M T Tórtola; N Cobos; T González; F Fernández
Journal:  Enferm Infecc Microbiol Clin       Date:  1992-01       Impact factor: 1.731

10.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

Authors:  J J LiPuma; S E Dasen; D W Nielson; R C Stern; T L Stull
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321
  10 in total
  2 in total

1.  Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center.

Authors:  J A Richau; J H Leitão; M Correia; L Lito; M J Salgado; C Barreto; P Cescutti; I Sá-Correia
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers.

Authors:  C Segonds; E Bingen; G Couetdic; S Mathy; N Brahimi; N Marty; P Plesiat; Y Michel-Briand; G Chabanon
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.